DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Acutaas Chemicals Limited — Acquisition

NSE 1 hr ago·17 Oct 2026, 9:45 am

Acutaas Chemicals

Acutaas Chemicals Limited has announced a significant corporate development to the stock exchanges. The company has informed the market that it is pursuing an acquisition, a strategic move that involves buying another business entity to expand its operations.

For investors, this news is important because such deals are often aimed at boosting revenue, accessing new technologies, or entering fresh markets. Whether the acquisition will add value to the company depends on the financial health of the target and how well the two businesses can integrate together.

Investors should watch for further details in the official regulatory filings. Key information to look for includes the identity of the target company, the total cost of the deal, and the timeline for the transaction to be completed.